What it is
Epitalon is the synthetic tetrapeptide Ala-Glu-Asp-Gly (AEDG), designed from the amino acid composition of Epithalamin, a bovine pineal gland extract studied in the Soviet Union and Russia from the 1970s onward. Araj et al. (2025) describe roughly 25 years of in vitro, in vivo and in silico work on the peptide, most of it originating from Vladimir Khavinson's group in St Petersburg. The distinction between the peptide and the parent extract matters for reading the evidence, because the long human follow-up studies used the extract.
Mechanism of action
The mechanism most often proposed is transcriptional. Khavinson et al. (2003) reported that adding the peptide to telomerase-negative human fetal fibroblast cultures induced expression of the telomerase catalytic subunit, measurable telomerase activity and telomere elongation, which the authors interpreted as reactivation of a silenced telomerase gene in somatic cells. Al-dulaimi et al. (2025) extended this to additional human cell lines and reported telomere lengthening through telomerase upregulation in normal cells and through the alternative lengthening of telomeres route in cancer lines. Araj et al. (2025) summarize further proposed activity as antioxidant, antimutagenic and neuroendocrine, including effects on melatonin signaling. These remain proposed mechanisms: the supporting work is in cultured cells and rodents, and the structural and physicochemical characterization is thin.
What it’s most studied for
Two questions dominate the literature. The first is telomere biology: whether a short peptide can raise telomerase activity and extend telomeres in cultured human cells, which is the basis for the longevity framing around it. The second is rodent aging: whether monthly injection courses alter lifespan distributions, age-related reproductive decline, chromosomal damage and spontaneous tumor incidence in mice. A smaller literature examines neuroendocrine and antioxidant markers. Human longevity claims circulating about this compound generally trace back to studies of Epithalamin, the pineal extract, in elderly Russian cardiology patients, not to trials of the tetrapeptide itself.
Notable findings
Each finding carries the species or population it was observed in and the dose that study used. Doses are reported as research context, exactly as published. They are not guidance.
Telomere length in human cell lines
Al-dulaimi et al. (2025) measured telomere length in cultured human cell lines. In normal cells they reported dose-dependent telomere extension accompanied by hTERT and telomerase upregulation, and in cancer cells telomere extension through activation of the alternative lengthening of telomeres route. A correction was published in the same journal in November 2025 replacing the figures in Figures 1, 2 and 3; the correction does not state that the conclusions changed.
- Dose studied
- Applied to cultured human cell lines across a concentration range the authors describe as dose-dependent; the abstract does not state the concentrations used
[1] Al-dulaimi S et al. · 2025 · PMID 40908429 ↗
Telomerase induction in fetal fibroblasts
Khavinson et al. (2003) added the peptide to telomerase-negative human fetal fibroblast cultures and reported induction of the telomerase catalytic subunit, measurable enzymatic activity and telomere elongation. The published abstract reports these outcomes qualitatively and does not give fold changes, sample sizes or statistical tests, which limits how much weight the result can carry. It is the origin point for most later telomere claims about this peptide.
- Dose studied
- Added to telomerase-negative human fetal fibroblast cultures; the abstract does not report the concentration used
[3] Khavinson VKh et al. · 2003 · PMID 12937682 ↗
Lifespan and tumor incidence in mice
Anisimov et al. (2003) treated female outbred Swiss-derived SHR mice from 3 months of age until natural death, 54 animals per group. Mean lifespan was unchanged, while the last 10% of survivors lived 13.3% longer (P<0.01) and maximum lifespan was 12.3% higher than controls. The authors also reported 17.1% fewer chromosome aberrations in bone marrow cells (P<0.05), slower age-related loss of estrous cycling, unchanged total spontaneous tumor incidence, and a 6.0-fold reduction in leukemia.
- Dose studied
- Subcutaneous injections on 5 consecutive days every month, from 3 months of age until natural death (female Swiss-derived SHR mice, 54 per group)
[4] Anisimov VN et al. · 2003 · PMID 14501183 ↗
Twelve-year study of the parent pineal extract
Korkushko et al. (2006) reported a 12-year randomized study in elderly patients with coronary heart disease and accelerated cardiovascular aging, comparing repeated courses of the Epithalamin pineal extract plus basic therapy against basic therapy alone. The authors reported 28% fewer deaths in the extract group and roughly twofold lower cardiovascular mortality. This study used the bovine pineal extract rather than the synthetic tetrapeptide, was conducted by the group that developed both, and has not been independently replicated.
- Dose studied
- Repeated courses of the Epithalamin pineal extract alongside basic cardiac therapy over 12 years, elderly patients; the abstract does not state the amount per course
[5] Korkushko OV et al. · 2006 · DOI 10.1007/s10517-006-0365-z ↗
Study quality
No controlled trial of the Epitalon tetrapeptide itself has been published, so the direct evidence is in vitro work in human cell lines and rodent lifespan studies in mice. Nearly all of it comes from one research group in St Petersburg, and the key 2003 telomerase paper reports results qualitatively without statistics. The 2003 mouse study is the strongest design in the set, with 54 animals per group followed to natural death, and its headline result is narrow: maximum and late-survivor lifespan shifted while mean lifespan did not. The 2025 cell line study is independent of that group but required a correction to three figures. The human mortality findings attach to Epithalamin, a different preparation. No controlled safety data for the tetrapeptide in humans has been published; the mouse work reported no treatment-related toxicity.
On the research desk
Recent records on Epitalon from the Alpha Helix research feed, each with its evidence tier and citation.
References
- 1Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. PMID 40908429
- 2Correction: Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. PMID 41240216
- 3Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. PMID 12937682
- 4Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. PMID 14501183
- 5Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging. Bulletin of Experimental Biology and Medicine. DOI 10.1007/s10517-006-0365-z
- 6Overview of Epitalon: highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences. PMID 40141333
- 7July 23-24, 2026 Meeting of the Pharmacy Compounding Advisory Committee: votes on nominated bulk drug substances for the 503A list. U.S. Food and Drug Administration.
Free guide
Want more than the summary?
Get our free research guide, or tell us about your practice and we’ll get back to you.